NCT00326898-D8
Dataset Information
Dataset ID: NCT00326898-D8
PubMed ID (PMID):
Publication Title:
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Description of Dataset:
This dataset, NCT00326898-D8, contains information on the time interval from randomization to treatment start date, treatment dose and reasons for dose modification by cycle. NCT00326898-D9 contains toxicity data (by cycle) on hypertension, diarrhea, hand-foot reaction, and/or rash/desquamation while on treatment for E2805 study. Data in both NCT00326898-D8 and -D9 datasets were collected on the trial but not published. Patients in the NCT00326898-D3, -D4, -D8, and –D9 data submissions have the same deidentified patient IDs.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT00326898 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®